- Who can participate: Participants aged 18 to 65 years with a diagnosis of chronic pain for at least six months are eligible. Key exclusions include individuals with a history of drug abuse or those currently using other investigational treatments.
- Study details: Participants will be randomly assigned to receive either the investigational drug or a placebo. The study will involve regular assessments of pain levels and quality of life through questionnaires and clinical evaluations.
How understandable was the trial content above?
Hard to understand
Easy to understand
